Cubist Systematic Strategies, LLC Sage Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $4.62 Million - $7.81 Million	436,566 Added 831.19%	489,089 $5.31 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $553,256 - $800,765	29,713 Added 130.26%	52,523 $984,000
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $390,051 - $507,750	22,810 New	22,810 $494,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $336,663 - $493,110	-8,282 Reduced 34.01%	16,071 $755,000
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $147,924 - $184,836	3,969 Added 19.47%	24,353 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$32.2 - $43.61 $272,090 - $368,504	-8,450 Reduced 29.31%	20,384 $777,000
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $1.68 Million - $2.25 Million	-52,089 Reduced 64.37%	28,834 $1.13 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $535,346 - $739,019	19,453 Added 31.65%	80,923 $2.61 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $1.22 Million - $1.82 Million	-39,760 Reduced 39.28%	61,470 $2.04 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $413,070 - $525,088	-11,146 Reduced 9.92%	101,230 $4.31 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $3.22 Million - $4.59 Million	80,036 Added 247.48%	112,376 $4.98 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $498,859 - $720,746	9,090 Added 39.1%	32,340 $1.84 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $1.64 Million - $2.25 Million	23,250 New	23,250 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$58.41 - $89.06 $2.42 Million - $3.69 Million	-41,459 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$41.13 - $62.45 $122,567 - $186,101	2,980 Added 7.74%	41,459 $2.53 Million
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $1.08 Million - $1.79 Million	-41,507 Reduced 51.89%	38,479 $1.6 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $192,516 - $568,640	7,362 Added 10.14%	79,986 $2.3 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $4.17 Million - $10.7 Million	69,286 Added 2075.67%	72,624 $5.24 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $77,580 - $105,047	553 Added 19.86%	3,338 $468,000
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $740,947 - $859,424	-4,694 Reduced 62.76%	2,785 $510,000
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $132,476 - $242,692	1,483 Added 24.73%	7,479 $1.19 Million
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $469,598 - $800,678	-5,731 Reduced 48.87%	5,996 $574,000
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $8.89 Million - $10.9 Million	-64,383 Reduced 84.59%	11,727 $1.66 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $10.7 Million - $13.4 Million	76,110 New	76,110 $11.9 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $53,252 - $67,315	-350 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $42,625 - $117,472	-702 Reduced 66.73%	350 $58,000
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $64,592 - $93,123	1,052	1,052 $66,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account